Pharmaron Biologics and Cell & Gene Therapy
Pharmaceutical Manufacturing • 
Daxing District, Beijing, China • 101-200 Employees
Company overview
| Headquarters | 6 Taihe Road, BDA, Beijing, 100176, CN |
| Website | |
| NAICS | 3254 |
| Keywords | Analytics, CRO, AAV, Viral, Biologics, Cdmo, Cell And Gene Therapy, Gene Therapies, Biomanufacturing, Mammalian, Plasmids, Mass Spec, Characterisation, Ind-Enabling |
| Founded | 2004 |
| Employees | 101-200 |
| Socials |
Key Contacts at Pharmaron Biologics and Cell & Gene Therapy
Kassim Kolia
Executive Director & Head Of Europe Business Development, Biologics Cdmo
Tony Meaden
Associate Director Quality Qp And Core Team Leader
Shirley Lam
Associate Director, Business Development - Uk Cell & Gene Therapy
Rob Olliver
Director
Verity Nancollis
Associate Director
Thomas Klem
Sr. Director, Cgt & Biologics
Kieron Mcintyre
Director Analytical Services
Angela Massey
Director Analytical Sciences - Analytical Development
Andrew Foulkes
Director Of Finance
Jinyue Dong
Associate Director
Pharmaron Biologics and Cell & Gene Therapy Email Formats
Pharmaron Biologics and Cell & Gene Therapy uses 1 email format. The most common is {first name}.{last name} (e.g., john.doe@pharmaron-uk.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@pharmaron-uk.com | 100% |
About Pharmaron Biologics and Cell & Gene Therapy
Pharmaron: Global Life Sciences Services Provider Stock Code: 300759.SZ/3759.HK Founded in 2004, Pharmaron is a leading life sciences service provider offering integrated Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) solutions across the biologics and cell and gene therapy (CGT) development spectrum - from discovery to market. With a global presence, advanced technologies, and regulatory expertise, we help partners accelerate timelines, reduce risks, and bring innovative therapies to patients faster. Biologics and CGT Solutions ----------------------------------------------- > Antibody Discovery and Protein Science – Supporting biologics programs from discovery to clinical development. > Developability Assessment – Evaluating candidate molecules for manufacturability and therapeutic potential. > Process Development – Optimizing and scaling upstream and downstream processes. > Small-Scale Non-GMP and cGMP Manufacturing – Flexible production solutions for early development and clinical-scale needs. > Analytical and Quality Control – Comprehensive testing to ensure product integrity and compliance. > Regulatory Support – Guidance for global submissions, including IND and BLA filings. > CGT Laboratory Services – In vitro assays, in vivo studies, biodistribution, and bioanalysis. > Gene Therapy CDMO Services – Plasmid DNA manufacturing, viral vector development, and GMP manufacturing. Connect with us to explore how Pharmaron can support your journey from discovery to market Biologics & Cell and Gene Therapy | Pharmaron Keywords: CRO, CDMO, biologics development, CGT, antibody discovery, protein science, developability assessment, process development, cGMP manufacturing, analytical development, quality control, regulatory affairs, IND, BLA, cell and gene therapy (CGT)
Pharmaron Biologics and Cell & Gene Therapy revenue & valuation
| Annual revenue | $13,300,000 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $42,500,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 101-200
Seniority
Employees
Employees by Department
Pharmaron Biologics and Cell & Gene Therapy has 59 employees across 8 departments.
Departments
Number of employees
Funding Data
Pharmaron Biologics and Cell & Gene Therapy has never raised funding before.
Italy
Frequently asked questions
4.8
40,000 users
